Understanding Early COPD

REFERENCES

1. 1.↵
   1. Badham C

   . An essay on bronchitis: with a supplement containing remarks on simple pulmonary abscess, 2nd edition. London: Printed for J. Callow; 1814.
2. 2.↵
   1. Laennec R

   . A treatise on the diseases of the chest. London; 1821.
3. 3.↵
   1. Briscoe WA,
   2. Nash ES

   . The slow space in chronic obstructive pulmonary diseases. Ann N Y Acad Sci 1965;121:706-722.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Fletcher C,
   2. Peto R

   . The natural history of chronic airflow obstruction. Br Med J 1977;1(6077):1645-1648.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Agustí A,
   2. Celli BR,
   3. Criner GJ,
   4. Halpin D,
   5. Anzueto A,
   6. Barnes P,
   7. et al

   . Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary. Am J Respir Crit Care Med 2023;207(7):819-837.

   OpenUrl
6. 6.↵
   1. Martinez FJ,
   2. Han MK,
   3. Allinson JP,
   4. Barr RG,
   5. Boucher RC,
   6. Calverley PMA,
   7. et al

   . At the root: defining and halting progression of early chronic obstructive pulmonary sisease. Am J Respir Crit Care Med 2018;197(12):1540-1551.

   OpenUrlPubMed
7. 7.↵
   1. Pauwels RA,
   2. Buist AS,
   3. Calverley PM,
   4. Jenkins CR,
   5. Hurd SS

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256-1276.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Rabe KF,
   2. Hurd S,
   3. Anzueto A,
   4. Barnes PJ,
   5. Buist SA,
   6. Calverley P,
   7. et al

   ; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Vestbo J,
   2. Lange P

   . Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166(3):329-332.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Regan EA,
    2. Lynch DA,
    3. Curran-Everett D,
    4. Curtis JL,
    5. Austin JH,
    6. Grenier PA,
    7. et al

    ; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 2015;175(9):1539-1549.

    OpenUrl
11. 11.↵
    1. Wan ES,
    2. Castaldi PJ,
    3. Cho MH,
    4. Hokanson JE,
    5. Regan EA,
    6. Make BJ,
    7. et al

    ; COPDGene Investigators. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res 2014;15(1):89.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Wijnant SRA,
    2. De Roos E,
    3. Kavousi M,
    4. Stricker BH,
    5. Terzikhan N,
    6. Lahousse L,
    7. et al

    . Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study. Eur Respir J 2020;55(1):1901217.

    OpenUrlPubMed
13. 13.↵
    1. Martinez CH,
    2. Kim V,
    3. Chen Y,
    4. Kazerooni EA,
    5. Murray S,
    6. Criner GJ,
    7. et al

    ; COPDGene Investigators. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med 2014;108(3):491-499.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Woodruff PG,
    2. Barr RG,
    3. Bleecker E,
    4. Christenson SA,
    5. Couper D,
    6. Curtis JL,
    7. et al

    ; SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016;374(19):1811-1821.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Kesimer M,
    2. Ford AA,
    3. Ceppe A,
    4. Radicioni G,
    5. Cao R,
    6. Davis CW,
    7. et al

    . Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med 2017;377(10):911-922.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Han MK,
    2. Agusti A,
    3. Celli BR,
    4. Criner GJ,
    5. Halpin DMG,
    6. Roche N,
    7. et al

    . From GOLD 0 to pre-COPD. Am J Respir Crit Care Med 2021;203(4):414-423.

    OpenUrlPubMed
17. 17.↵
    1. Tan WC,
    2. Bourbeau J,
    3. Hernandez P,
    4. Chapman KR,
    5. Cowie R,
    6. FitzGerald JM,
    7. et al

    ; CanCOLD Collaborative Research Group. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax 2014;69(8):709-717.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Han MK,
    2. Ye W,
    3. Wang D,
    4. White E,
    5. Arjomandi M,
    6. Barjaktarevic IZ,
    7. et al

    ; RETHINC Study Group. Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function. N Engl J Med 2022;387(13):1173-1184.

    OpenUrl
19. 19.↵
    1. Lowe KE,
    2. Regan EA,
    3. Anzueto A,
    4. Austin E,
    5. Austin JHM,
    6. Beaty TH,
    7. et al

    . COPDGene 2019: Redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis 2019;6(5):384-399.

    OpenUrl
20. 20.↵
    1. Stolz D,
    2. Mkorombindo T,
    3. Schumann DM,
    4. Agusti A,
    5. Ash SY,
    6. Bafadhel M,
    7. et al

    . Towards the elimination of chronic obstructive pulmonary disease: a Lancet commission. Lancet 2022;400(10356):921-972.

    OpenUrlCrossRef
21. 21.↵
    1. Lange P,
    2. Celli B,
    3. Agustí A,
    4. Boje Jensen G,
    5. Divo M,
    6. Faner R,
    7. et al

    . Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015;373(2):111-122.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. McDonough JE,
    2. Yuan R,
    3. Suzuki M,
    4. Seyednejad N,
    5. Elliott WM,
    6. Sanchez PG,
    7. et al

    . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567-1575.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Macklem PT

    . Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35(3):676-680.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Johns DP,
    2. Walters JA,
    3. Walters EH

    . Diagnosis and early detection of COPD using spirometry. J Thorac Dis 2014;6(11):1557-1569.

    OpenUrlPubMed
25. 25.↵
    1. Hogg JC,
    2. Paré PD,
    3. Hackett TL

    . The contribution of small-airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev 2017;97(2):529-552.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Galbán CJ,
    2. Han MK,
    3. Boes JL,
    4. Chughtai KA,
    5. Meyer CR,
    6. Johnson TD,
    7. et al

    . Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012;18(11):1711-1715.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Bhatt SP,
    2. Soler X,
    3. Wang X,
    4. Murray S,
    5. Anzueto AR,
    6. Beaty TH,
    7. et al

    ; COPDGene Investigators. Association between functional small-airway disease and FEV₁ decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016;194(2):178-184.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Labaki WW,
    2. Gu T,
    3. Murray S,
    4. Hatt CR,
    5. Galbán CJ,
    6. Ross BD,
    7. et al

    . Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers. Acad Radiol 2019;26(2):217-223.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Kirby M,
    2. Tanabe N,
    3. Tan WC,
    4. Zhou G,
    5. Obeidat M,
    6. Hague CJ,
    7. et al

    ; CanCOLD Collaborative Research Group, the Canadian Respiratory Research Network. Total airway count on computed tomography and the risk of chronic obstructive pulmonary disease progression. Findings from a population-based study. Am J Respir Crit Care Med 2018;197(1):56-65.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Criner RN,
    2. Hatt CR,
    3. Galban CJ,
    4. Kazerooni EA,
    5. Lynch DA,
    6. McCormack MC,
    7. et al

    . Relationship between diffusion capacity and small-airway abnormality in COPDGene. Respir Res 2019;20(1):269.

    OpenUrl
31. 31.
    1. Bednarek M,
    2. Grabicki M,
    3. Piorunek T,
    4. Batura-Gabryel H

    . Current place of impulse oscillometry in the assessment of pulmonary diseases. Respir Med 2020;170:105952.

    OpenUrl